Protection against retinopathy in T2D

Recent research has found that sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with a lower risk for sight-threatening retinopathy than other second-line glucose-lowering medications in

Read More »

Arthritis offers hope for T1D

A commonly prescribed drug for rheumatoid arthritis could be used to slow the progress of Type 1 diabetes, new research shows.In the study, the immunotherapy

Read More »